Halozyme Therapeutics Inc (HALO)
- Exchange
- NASDAQ
- Symbol
- HALO
- Sector
- Life Sciences
- Industry
- Biological Products, (no Disgnostic Substances)
- Description
- Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California.
- Country
- USA
Stock price
At close: November 6, 2024
-
Open60.55
-
High61.49
-
Low58.01
-
Close60.63
-
Volume1,530,020
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
3.31
Receivables turnover
—
Payables turnover
35.73
Working capital turnover
1.28
Days of inventory on hand (DOH)
110.31
Days of sales outstanding (DSO)
—
Number of days of payables
10.21
Fixed asset turnover
21.27
Total asset turnover
0.47
Current ratio
6.64
Quick ratio
2.99
Cash ratio
2.99
Cash conversion cycle
100.09
Debt-to-assets ratio
0.86
Debt-to-capital ratio
0.95
Debt-to-equity ratio
17.89
Financial leverage ratio
20.68
Interest coverage
19.56
Gross profit margin
47.90%
Operating profit margin
41.66%
Pretax margin
42.98%
Net profit margin
34.75%
Operating return on assets (Operating ROA)
19.48%
Return on assets (ROA)
16.25%
Return on total capital
23.19%
Return on equity (ROE)
336.00%